Nexium Uses, Dosage, Side Effects and more
Nexium is under investigation in clinical trial NCT03416491 (Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C).
| Attribute | Details |
|---|---|
| Trade Name | Nexium |
| Generic | Coblopasvir |
| Coblopasvir Other Names | Coblopasvir |
| Weight | 20mg, 40mg, , 49.3mg, 10mg, 2.5mg, 5mg |
| Type | Tablet, Coated, Powder, For Solution, Oral Delayed Release Capsule, Oral Delayed Release Tablet, Oral Powder For Reconstitution, Delayed Release, Oral, Capsule, Granule, Injection, Powder For Injection |
| Formula | C41H50N8O8 |
| Weight | Average: 782.899 Monoisotopic: 782.375160602 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | Astrazeneca Uk Limited, Astrazeneca, Astra Zeneca |
| Available Country | United Kingdom, Canada, Australia, Saudi Arabia, United States, Netherlands, Portugal, Switzerland, Indonesia, Sweden, Nigeria, |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
